We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA approved phase 3 trials of iSCIB1+ DNA vaccine against melanoma. Survival increase of 24%. Find out when the drug will be available and who it will help.
